Literature DB >> 22337738

Is carbamazepine safe to take during pregnancy?

Jeremy Matlow, Gideon Koren.   

Abstract

QUESTION: Some of my pregnant patients are afraid to take their antiepileptic drugs during pregnancy because of the known risk of malformations and the neurodevelopmental problems associated with valproic acid. Are there similar concerns with carbamazepine? ANSWER: Similar to valproic acid, carbamazepine increases the risk of neural tube defects; however, it does not increase the risk of other malformations. Carbamazepine is also not associated with an increased risk of developmental delay.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337738      PMCID: PMC3279268     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  Antiepileptic drug regimens and major congenital abnormalities in the offspring.

Authors:  E B Samrén; C M van Duijn; G C Christiaens; A Hofman; D Lindhout
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

2.  Major malformations in offspring of women with epilepsy.

Authors:  Erja Kaaja; Risto Kaaja; Vilho Hiilesmaa
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

3.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

Review 4.  Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy.

Authors:  A V Delgado-Escueta; D Janz
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

5.  Maternal epilepsy and abnormalities of the fetus and newborn.

Authors:  B D Speidel; S R Meadow
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  Language skills of school-aged children prenatally exposed to antiepileptic drugs.

Authors:  C Nadebaum; V A Anderson; F Vajda; D C Reutens; S Barton; A G Wood
Journal:  Neurology       Date:  2011-02-22       Impact factor: 9.910

Review 7.  Epileptic disorders in pregnancy: an overview.

Authors:  Cynthia L Harden; Nitin K Sethi
Journal:  Curr Opin Obstet Gynecol       Date:  2008-12       Impact factor: 1.927

8.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

Review 9.  Antiepileptic drugs as human teratogens.

Authors:  Mervyn J Eadie
Journal:  Expert Opin Drug Saf       Date:  2008-03       Impact factor: 4.250

Review 10.  Spina bifida in infants of women treated with carbamazepine during pregnancy.

Authors:  F W Rosa
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

View more
  11 in total

1.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

2.  Drug use and/or exposure in pregnancy: Presence of risk versus quantity of risk.

Authors:  Yusuf Cem Kaplan
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

Review 3.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-12-06

Review 4.  Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

Review 5.  Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Catrin Tudur Smith; Jennifer Weston; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

Review 6.  Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-02-27

7.  Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Anthony G Marson; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-07-18

Review 8.  Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Jennifer Weston; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28

Review 9.  Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.

Authors:  Yusuf Cem Kaplan; Omer Demir
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

10.  Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Anthony G Marson; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.